Optimind Pharma Corp. (CSE:OMND)
 0.0050
 -0.0050 (-50.00%)
  Aug 19, 2025, 1:59 PM EDT
Optimind Pharma Revenue
Optimind Pharma had revenue of 35.71K CAD in the quarter ending May 31, 2025, with 122.47% growth. This brings the company's revenue in the last twelve months to 138.02K, up 41.22% year-over-year. In the fiscal year ending February 28, 2025, Optimind Pharma had annual revenue of 118.37K, down -3.73%.
Revenue (ttm) 
 138.02K
Revenue Growth 
 +41.22%
P/S Ratio 
 3.74
Revenue / Employee 
 n/a
Employees 
 n/a
Market Cap 
515.74K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Feb 28, 2025 | 118.37K | -4.59K | -3.73% | 
| Feb 29, 2024 | 122.96K | -47.15K | -27.72% | 
| Feb 28, 2023 | 170.11K | 70.42K | 70.64% | 
| Feb 28, 2022 | 99.69K | - | - | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition